Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1977 Jul 23;117(2):151–156.

Prevention of congenital rubella.

J P Welch
PMCID: PMC1879698  PMID: 326368

Abstract

The vaccine of choice for rubella vaccination is considered to be RA 27/3, based on frequency of side effects, duration of immunity, antigenic potential and rate of reinfection by wild virus. The most appropriate individuals to be vaccinated are prepubertal schoolgirls and susceptible members of other high-risk groups, and a nationwide immunization program is suggested. Premarital determination of rubella-immune status should be mandatory for all women of childbearing age. A favourable cost/benefit ratio for rubella vaccination seems highly probable. The use of a rubella "fact sheet" to provide education and information for those at risk is strongly recommended.

Full text

PDF
151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chang T. W., DesRosiers S., Weinstein L. Clinical and serologic studies of an outbreak of rubella in a vaccinated population. N Engl J Med. 1970 Jul 30;283(5):246–248. doi: 10.1056/NEJM197007302830507. [DOI] [PubMed] [Google Scholar]
  2. Cooper L. Z., Krugman S. Clinical manifestations of postnatal and congenital rubella. Arch Ophthalmol. 1967 Apr;77(4):434–439. doi: 10.1001/archopht.1967.00980020436004. [DOI] [PubMed] [Google Scholar]
  3. Dudgeon J. A. The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps. Practitioner. 1975 Sep;215(1287):299–309. [PubMed] [Google Scholar]
  4. Faulkner R. S., Gough D. A. Rubella 1974 and its aftermath, congenital rubella syndrome. Can Med Assoc J. 1976 Jan 24;114(2):115–119. [PMC free article] [PubMed] [Google Scholar]
  5. Freestone D. S., Reynolds G. M., McKinnon J. A., Prydie J. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley. Br J Prev Soc Med. 1975 Dec;29(4):258–261. doi: 10.1136/jech.29.4.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grillner L. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines. J Infect Dis. 1976 Jun;133(6):637–641. doi: 10.1093/infdis/133.6.637. [DOI] [PubMed] [Google Scholar]
  7. Gumpel S. M., Hayes K., Dudgeon J. A. Congenital perceptive deafness: role of intrauterine rubella. Br Med J. 1971 May 8;2(5757):300–304. doi: 10.1136/bmj.2.5757.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hambling M. H. Effect of a vaccination programme on the distribution of rubella antibodies in women of childbearing age. Lancet. 1975 May 17;1(7916):1130–1133. doi: 10.1016/s0140-6736(75)92514-3. [DOI] [PubMed] [Google Scholar]
  9. Horstmann D. M. Controlling rubella: problems and perspectives. Ann Intern Med. 1975 Sep;83(3):412–417. doi: 10.7326/0003-4819-83-3-412. [DOI] [PubMed] [Google Scholar]
  10. Horstmann D. M., Liebhaber H., Le Bouvier G. L., Rosenberg D. A., Halstead S. B. Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic. N Engl J Med. 1970 Oct 8;283(15):771–778. doi: 10.1056/NEJM197010082831501. [DOI] [PubMed] [Google Scholar]
  11. Horstmann D. M. Need for monitoring vaccinated populations for immunity levels. Prog Med Virol. 1973;16:215–240. [PubMed] [Google Scholar]
  12. Horstmann D. M., Pajot T. G., Liebhaber H. Epidemiology of rubella. Subclinical infection and occurrence of reinfection. Am J Dis Child. 1969 Jul;118(1):133–136. [PubMed] [Google Scholar]
  13. Joncas J. H. Letter: Rubella immunization. Can Med Assoc J. 1974 Nov 2;111(9):907–911. [PMC free article] [PubMed] [Google Scholar]
  14. Judson F. N., Shaw B. S., Vernon T. M., Jr Mandatory premarital rubella serologic testing in Colorado. A preliminary report. JAMA. 1974 Aug 26;229(9):1200–1202. [PubMed] [Google Scholar]
  15. Katz M. Editorial: Rubella vaccine. J Pediatr. 1974 Apr;84(4):615–616. doi: 10.1016/s0022-3476(74)80705-5. [DOI] [PubMed] [Google Scholar]
  16. Krugman S., Katz S. L. Editorial: Rubella immunization: a five-year progress report. N Engl J Med. 1974 Jun 13;290(24):1375–1376. doi: 10.1056/NEJM197406132902410. [DOI] [PubMed] [Google Scholar]
  17. Le Bouvier G. L., Plotkin S. A. Precipitin responses to rubella vaccine RA 27-3. J Infect Dis. 1971 Feb;123(2):220–223. doi: 10.1093/infdis/123.2.220. [DOI] [PubMed] [Google Scholar]
  18. Lehane D. E., Newberg N., Beam W. E., Jr Evaluation of rubella herd immunity during an epidemic. JAMA. 1970 Sep 28;213(13):2236–2239. [PubMed] [Google Scholar]
  19. Liebhaber H., Ingalls T. H., Le Bouvier G. L., Horstmann D. M. Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years. Am J Dis Child. 1972 Feb;123(2):133–136. [PubMed] [Google Scholar]
  20. McLean D. M. The rubella situation in Canada--1972. Can J Public Health. 1972 Sep-Oct;63(5):385–391. [PubMed] [Google Scholar]
  21. Modlin J. F., Herrmann K., Brandling-Bennett A. D., Eddins D. L., Hayden G. F. Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women. N Engl J Med. 1976 Apr 29;294(18):972–974. doi: 10.1056/NEJM197604292941802. [DOI] [PubMed] [Google Scholar]
  22. Neff J. M., Carver D. H. Rubella immunization: reconsideration of our present policy. Am J Epidemiol. 1970 Sep;92(3):162–163. doi: 10.1093/oxfordjournals.aje.a121193. [DOI] [PubMed] [Google Scholar]
  23. Plotkin S. A., Farquhar J. D., Ogra P. L. Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA. 1973 Aug 6;225(6):585–590. doi: 10.1001/jama.225.6.585. [DOI] [PubMed] [Google Scholar]
  24. Rachelefsky G. S., Herrmann K. L. Congenital rubella surveillance following epidemic rubella in a partially vaccinated community. J Pediatr. 1974 Apr;84(4):474–478. doi: 10.1016/s0022-3476(74)80663-3. [DOI] [PubMed] [Google Scholar]
  25. Schoenbaum S. C., Biano S., Mack T. Epidemiology of congenital rubella syndrome. The role of maternal parity. JAMA. 1975 Jul 14;233(2):151–155. [PubMed] [Google Scholar]
  26. Stoffman J. M., Wolfish M. G. The susceptibility of adolescent girls to rubella. Observations on 297 girls in Toronto. Clin Pediatr (Phila) 1976 Jul;15(7):625–626. doi: 10.1177/000992287601500709. [DOI] [PubMed] [Google Scholar]
  27. Wallace R. B., Isacson P. Comparative trial of HPV-77, DE-5 and RA 27-3 live-attenuated rubella vaccines. Am J Dis Child. 1972 Oct;124(4):536–538. doi: 10.1001/archpedi.1972.02110160074007. [DOI] [PubMed] [Google Scholar]
  28. Wilkins J., Leedom J. M., Portnoy B., Salvatore M. A. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies. Am J Dis Child. 1969 Aug;118(2):275–294. doi: 10.1001/archpedi.1969.02100040277025. [DOI] [PubMed] [Google Scholar]
  29. Wyll S. A., Herrmann K. L., Abrutyn E., Murphy G. D., 3rd, Witte J. J. Rubella booster immunization. Serologic response to a second dose of vaccine. JAMA. 1971 May 31;216(9):1451–1453. doi: 10.1001/jama.216.9.1451. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES